Skip to main content
ConductScienceScienceDex

Joji Suzuki

NIH Rank #11222
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10951981Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#11,222
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Joji Suzuki. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Joji Suzuki as a PI. Multi-PI records show the full award amount for context.

  • 1R21DA060304-01A1R21
    Semaglutide for the treatment of opioid use disorder: A pilot randomized controlled trial
    Brigham and Women's Hospital
    $492.3K
    award amount
  • 5R21DA058119-02R21
    Ketamine for the treatment for opioid use disorder and suicidal ideation in the emergency department
    Brigham and Women's Hospital
    $268.5K
    award amount
  • 5R21DA057545-02R21
    Oral buprenorphine as a novel low-dose induction strategy for individuals with opioid use disorder
    Brigham and Women's Hospital
    $265.1K
    award amount
  • 1R21DA060411-01R21
    Extended release buprenorphine as a novel low-dose induction strategy
    Brigham and Women's Hospital
    $235.5K
    award amount

Award organization

Organizations that administered FY2024 awards listing Joji Suzuki as a PI.

FY2024 award administered by Brigham and Women's Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #2462
  6. 2026
    Entered Top 25% Nationally
    Ranked #2462

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Joji Suzuki.

Charlotte Goldfine
Brigham and Women's Hospital
1
shared award
Peter R Chai
Brigham and Women's Hospital
1
shared award

Explore further

Find collaborators for Joji Suzuki

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →